Clinical Trial Update: Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating epcoritamab in chronic lymphocytic leukemia and Richter syndrome. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Richter Syndrome

Drugs mentioned

• Epcoritamab (Epkinly) (epcoritamab)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Leukemia, Chronic Lymphocytic, Richter Syndrome | Phase 1 | Status: ACTIVE_NOT_RECRUITING